Physician profile
Golta Rasouli
NPI 1154765667
$1,580.24
in general payments reported to CMS, 2019-2025
17 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Phlebology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $187 · 2021: $44.83 · 2022: $50.74 · 2023: $158 · 2024: $429 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $363.95 | 2020-2025 | Novachor, Puraply, Cygnus Dual |
| Almirall LLC | $313.23 | 2019 | |
| Revance Therapeutics, INC. | $277.16 | 2024-2025 | Daxxify |
| Biofrontera INC. | $113.66 | 2022-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Merz North America, INC. | $98.00 | 2020 | |
| Amgen INC. | $73.78 | 2025 | Otezla |
| Galderma Laboratories, L.P. | $68.58 | 2020-2021 | |
| Boston Scientific Corporation | $59.76 | 2021-2024 | Varithena Administration Pack |
| Smith+Nephew, INC. | $45.06 | 2025 | Oasis, Collagenase Santyl |
| Convatec INC. | $33.22 | 2024-2025 | |
| Allergan, INC. | $23.56 | 2022 | |
| Next Science LLC | $21.83 | 2023 | Xperience, Blastx, Surgx |
| Sun Pharmaceutical Industries INC. | $21.63 | 2020 | |
| Abbvie INC. | $18.58 | 2019 | |
| Pfizer INC. | $18.04 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $17.27 | 2025 | |
| Ge Healthcare | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Golta Rasouli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.